Literature DB >> 30259150

[A weakly negative recommendation is not an absolute "no" : Comment on AWMF guideline recommendations for cannabis-based medicines in fibromyalgia syndrome].

W Häuser1,2, F Petzke3, M Nothacker4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30259150     DOI： 10.1007/s00482-018-0328-0

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  9 in total

Review 1.  [General treatment principles, coordination of care and patient education in fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].

Authors:  F Petzke; W Brückle; U Eidmann; P Heldmann; V Köllner; T Kühn; H Kühn-Becker; M Strunk-Richter; M Schiltenwolf; M Settan; M von Wachter; M Weigl; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

2.  [Methodology report of the 2017 guidelines on fibromyalgia syndrome].

Authors:  W Häuser; M Nothacker
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

3.  [Obligation of guideline recommendations: Perception survey among guideline developers].

Authors:  Tobias Weberschock; Andreas Dreher; Markus Follmann; Monika Nothacker; Ina Kopp; Stefanie Rosumek; Alexander Nast
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2016-06-21

4.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

Review 5.  [Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].

Authors:  C Sommer; R Alten; K-J Bär; M Bernateck; W Brückle; E Friedel; P Henningsen; F Petzke; T Tölle; N Üçeyler; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

6.  European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management.

Authors:  Winfried Häuser; David P Finn; Eija Kalso; Nevenka Krcevski-Skvarc; Hans-Georg Kress; Bart Morlion; Serge Perrot; Michael Schäfer; Chris Wells; Silviu Brill
Journal:  Eur J Pain       Date:  2018-09-04       Impact factor: 3.931

7.  Non-specific, functional, and somatoform bodily complaints.

Authors:  Rainer Schaefert; Constanze Hausteiner-Wiehle; Winfried Häuser; Joram Ronel; Markus Herrmann; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2012-11-23       Impact factor: 5.594

8.  Nabilone for the treatment of pain in fibromyalgia.

Authors:  Ryan Quinlan Skrabek; Lena Galimova; Karen Ethans; Daryl Perry
Journal:  J Pain       Date:  2007-11-05       Impact factor: 5.820

Review 9.  Cannabinoids for fibromyalgia.

Authors:  Brian Walitt; Petra Klose; Mary-Ann Fitzcharles; Tudor Phillips; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18
  9 in total
  2 in total

1.  [Pain and ageing].

Authors:  R Thiesemann
Journal:  Z Gerontol Geriatr       Date:  2018-12       Impact factor: 1.281

Review 2.  [Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland].

Authors:  Patric Bialas; Beate Drescher; Sven Gottschling; Stephanie Juckenhöfel; Dieter Konietzke; Wolfgang Kuntz; Isabell Kühne-Adler; Heidi Merl-Ripplinger; Diether Preisegger; Kathrein Schneider; Manfred Strauß; Patrick Welsch; Winfried Häuser
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.